A prototype of a bioartificial liver (BAL) based on suspension perfusion culture of porcine hepatocyte spheroids was developed at 150 ml scale. About 2% (4 x 10 9 cells) of whole human liver cells was immobi lized. The cell density in the bioreactor was 2.7 x 10 7 cells/ml, which was almost comparable to that of presently developed packed-bed-type BALs. The bioreactor was perfused with culture medium while retain ing spheroids. This was done using a rotating stainless filter (pore size 50 u,m). In vitro 8-h perfusion experiments utilizing both synthesized culture medium and 100% human plasma demonstrated the spheroids in the bioreactor had almost the same functions on a unit/cell basis as those in small-scale rotational culture. This indicated that the functional deterioration often associated with scaling up had been minimized. Rapid spheroid aggregation and dysfunction in specific human plasma pool must be eliminated before clinical application, although this phenomenon seemed to be inherent to porcine hepatocyte-based BALs. This proto type shows promise in meeting present clinical demands by achieving maximal metabolic activities even in the short term.
INTRODUCTION
In the very near future, porcine hepatocyte-based bio artificial livers (BALs) are expected to become effective in treating patients with acute liver failure and patients awaiting liver transplantation. The successful clinical trial by Watanabe et al. (27) regarding the use of their BALs as a bridge to orthotropic liver transplantation is encouraging. However, further improvement in the BAL system is required for the treatment of more severe cases, including patients with acute, subacute, or chronic liver failure. In fact, the life-saving effect by their BAL system was lowered in the treatment of such patients (27) .
The cell number that should be incorporated in a clin ically meaningful BAL system appears to be around 10-20% (2-4 x 10 10 cells) of a whole human liver (6, 27) . Laboratory-scale experiments using a 35-mm tissue cul ture dish (about 10 6 cells are immobilized) yield cells that function at their maximal metabolic rates, because such a culture condition has no mass transfer limitation to cause functional deterioration. The cell number in a BAL should be 10,000-20,000 times higher. Therefore, one would expect significant unit/cell number basis functional deterioration in scaling up to clinical-scale BALs. In the case of some BAL immobilizing a small number of cells obtained from a rat (around 10 8 cells), almost the same functional expression per unit/cell num ber was attained (16) . Previously developed clinicalscale BALs, however, were not always addressed from this point of view, so that it has not been made clear as to what percentage of human liver function was actually obtained. In fact, in our clinical-scale packed-bed-type BAL reactor with radial flow design, significant reduc tion in the functions of immobilized porcine hepatocytes was observed compared with dish cultures on a unit/cell number basis (17) . However, the reactor doubled the sur vival time of the model pigs with liver failure (18) .
Concerning hepatocyte cultivation techniques, spheri cal aggregates (spheroids) were shown to have improved function more than conventional monolayer cultures in rats (10) . Some studies also examined the detailed struc ture of spheroids and revealed that the cells in spheroids have an intimate cell-to-cell contact just like that of in vivo liver tissue (5, 10) . Porcine hepatocyte spheroids rapidly formed by suspension culture were also shown to have such in vivo-like structure and improved func tions in almost the same manner as in rat hepatocytes (12, 22) . In addition, we recently showed the spheroids have relatively better tolerance against hypothermic preservation compared with freshly isolated single cells (23) . These are the advantages of spheroid culture over freshly isolated or monolayer-cultured hepatocytes in the application to BALs.
In order to improve the unit/cell number basis func tional expressions of porcine hepatocytes for BALs, in this study we have proposed a novel BAL reactor based on suspension perfusion culture of porcine hepatocyte spheroids. The prototype bioreactor immobilized 4 x 10 9 cells, about 2% of total cell number of a human liver, within 150-ml reactor volume. We have demonstrated good in vitro cellular performance of the reactor both in synthesized culture medium and in 100% human plasma for up to 8 h. The performance was good even when directly compared with small-scale dish level cultures.
MATERIALS AND METHODS

Cell Preparation and Spheroid Formation of Porcine Hepatocytes
We previously described the preparation of porcine hepatocytes from a Sangen strain pig weighing 10-15 kg by the collagenase perfusion method (17) . Usually over 2 x 10 10 cells with viability of over 85% were ob tained. A 1-1-scale spheroid formation of porcine hepa tocytes in a suspension culture vessel was recently de scribed (22) . In the previous procedure, the inoculated cell density was below 5 x 10 6 cells/ml and the time pe riod for formation was 24 h. In this study we could en hance the cellular density to 7.5 x 10 6 cells/ml with nei ther excess or disordered cells' aggregation nor oxygen shortage in the vessel. Also, we extended the culture duration up to 40 h to obtain much larger spheroids. The spheroids formed were washed once and resuspended with culture medium or human plasma for perfusion ex periments ( Fig. 1 ). The mean diameter was (278 ± 109) um (N=6). The reorganization ratio from the inoculum to spheroids ranged from 60% to 70%. Thus, we usually obtained spheroids consisting of 4-5 x 10 9 cells. that in the bioreactor. The perfusion rate was 60 ml/min.
Bioreactor and Perfusion Experiment
All the experimental apparatus was put in an incubator (BC-1200; Taitec Co., Saitama, Japan) whose tempera ture was set at 37°C. As a control experiment, 2x 10 7 cells in spheroids from the same preparation were put into a 60-mm sili conized glass dish with 5 ml of synthesized culture me dium, and were rotationally cultured at 60 rpm. In some experiments, 10'' of freshly isolated cells were inocu lated and cultured in monolayers in 35-mm dishes precoated with 0.03% type I collagen (Nitta Gelatin Co., Osaka, Japan).
Measurement of Various Cellular Activities and Cell Number
We measured ammonium removal, urea synthesis, 7ethoxycoumarin (7EC) metabolism, and albumin secre tion over 8 h of perfusion. Both synthesized culture me dium and human plasma were supplemented with 1 mM of ammonium chloride and 200 pM of 7EC. Ammonium chloride concentration was measured by indophenol meth od (15) . Urea concentration was measured by diacecylmonooxium methods followed by trichloroacetic acid protein precipitation (14) . Albumin concentration was measured by sandwich ELISA using standard porcine serum albumin (Yagai Co., Yamagata, Japan), anti-por cine serum albumin antibody, and its peroxidase-conjugated form (Bethyl Lab Inc., TX) (22) . Albumin secre tion capacity could be measured only in synthesized medium because of the cross-reaction of the purchased antibody to human albumin.
7EC dealkylation to 7-hydroxycoumarin (7HC) is one of established markers for cytochrome P-450 IA1 activity of cultured hepatocytes (8) . Both 7EC (Aldrich Japan, Tokyo, Japan) and 7HC (Dojin Chem., Kumamoto, Japan) concentrations were determined using fluo rescent measurement at two different emission wave lengths as previously described (24) . Briefly, the culture medium samples were first diluted 20 times with dis tilled water. Second, the maximal fluorescence for 7EC (394 nm) and 7HC (454 nm) when excited at the maxi mal emission wavelength for 7HC (333 nm) was mea sured. We ensured good additive linearity between the total emission and the individual concentrations of 7EC and 7HC, as long as each concentration did not exceed 10 pM. Each concentration was determined by referenc ing the calibration lines for pure 7EC and 7HC solu tions. This method was shown to give roughly reason able 7HC formation rates in the case of monolayer, spheroid, and sandwich collagen gel culture of rat hepa tocytes (8, 24) .
Regarding the intracellular 7EC and 7HC amount, ro tationally cultured spheroids (2 x 10 7 cells in 5 ml of culture medium) and monolayers (10 6 cells in 2 ml of culture medium) were collected by centrifugation after 8 h of exposure to 7EC-containing synthesized culture medium. The cells were washed once with phosphatebuffered saline (PBS) and resuspended with 5 and 2 ml of ice-cold acetone, for the spheroid culture and the monolayer culture, respectively. Then they were homogenated with a sonicator (Ohtake Works Co., Tokyo, Ja pan) at 50 W for 60 s on an ice bath. After centrifuged at 1000 rpm for 5 min, the 7EC and 7HC concentrations in the supernatant were determined by the same method as described above. We could recover 78 ± 6% for spheroid culture and 92 ± 14% for monolayer culture (N = 3) of the initially added 7EC on a molar-amount basis as the 7EC and 7HC amount in the culture medium and cells at 8 h. This recovery was slightly lower than a reported procedure employing chloroform/acetone (1:1) extraction (7) . However, extraction with acetone alone was suitable for our simple fluorescence measurement.
Cell number was determined first by wet weight of hepatocyte in a suspension aliquot (500-1000 ul (Fig. 4A ). There was no significant difference in produced 7HC concentrations between cultures, but the 7HC formation was much lower than anticipated from the 7EC reduction in the culture medium ( Fig. 4A, B ).
To further elucidate this very low 7HC formation by the spheroids, we compared 7EC metabolic capacities of the cells in rotationally cultured spheroids and in mono layers in collagen-coated dishes. The results are shown in Table 1 . Unexpectedly, all four indices, including the changes in intracellular 7EC and 7HC amount, clearly showed that the capacity of spheroids was remarkably lower than that of monolayers. Figure 5 shows the changes in the differences of DO concentrations between the inlet and outlet of the bio reactor. These correlate with the oxygen consumption rates by the spheroids in the bioreactor. After the initial increase, it reached a steady state and was held constant up to 8 h of culture.
After 8 h, we further continued the perfusion culture. However, at 12 h for run 1 and 11.5 h for run 2, we could not maintain the normal perfusion rate. Thus, we terminated the perfusion and dismantled the bioreactor. A large number of small spheroids (50-100 um in diam eter) were trapped with the filter. The number of spher oids successfully retained within the bioreactor was 75 ± 5% of the initial inoculum. Table 2 compares the unit/cell number basis cellular metabolic capacities in various culture systems utilizing porcine hepatocyte spheroids [this study; (19) ] and dish level monolayer culture (22, 25) . GOT leakage, albumin secretion, and oxygen consumption measured in this study are also included. Although the GOT leakage from the cells in the bioreactors or rotational cultures showed higher values than that of dish level monolayers, there was no difference among the suspension culture bioreac tor, packed-bed-type bioreactor, and rotational culture. Thus, the spheroids did not cause serious damage when continuously stirred in high-cell-density suspension. The spheroids in the bioreactor developed in this study had almost the same cellular activity compared with the spheroid's rotational cultures of 1/200 cell number (2 x 10 7 cells). Moreover, when compared with dish level monolayer cultures of 1/4000 cell number (1 x 10 6 cells) Perfusion time (hr) Figure 5 . Differences in oxygen concentrations (ADO) be tween the inlet and outlet of a reactor perfused with synthe sized culture medium (•, run 1; •, run 2). Each point repre sents a single determination. (22, 25) , higher albumin secretion of the spheroid culture was still seen in the bioreactor. Our previous packedbed-type bioreactor immobilizing preformed spheroids (19) had deteriorated functions particularly for albumin secretion if directly compared with dish level culture of spheroids (Table 1 ). However, the bioreactor developed in this study had significantly improved functional ex pressions including albumin secretion.
Bioreactor Performance in 100% Human Plasma
The first run in 100% human plasma was performed successfully. However, when the spheroids were resus pended with the human plasma pool for the second run, they caused very rapid aggregation within a few minutes.
We could not conduct any functional measurements in the second run. The third run could be done success fully. Thus, the phenomenon observed in the second run was due to hyperacute immune reaction occurring in special combination of porcine hepatocytes and human plasma. Figures 6 and 7 show concentrational changes in vari ous metabolites in 100% human plasma, together with those in the synthesized culture medium as described above. Originally contained ammonium concentrations before the addition of exogenous ammonium were 0.409 mM for run 1 and 0.502 mM for run 3 (Fig. 6A ). Re garding ammonium removal, 7EC reduction, and 7HC formation, there was no significant difference between the two cultures ( Figs. 6A, 7A, B ). However, urea syn thesis was inhibited to about half that in the synthesized medium ( Fig. 6B) . It seems to be due to the negative feedback effect by the very high urea concentration in human plasma. Figure 8 shows the reduction of oxygen concentration by the bioreactor. The oxygen consump tion rates of the spheroids in human plasma decreased slightly with the culture time compared with that in syn thesized culture medium, particularly after 5 h (Fig. 8) .
Clogging of the rotating filter forced us to terminate the perfusion experiments at 10.5 h for run 1 and 12.5 h for run 2. The remaining cell number at those times was 69 ± 8% of the initial inoculum. small-diameter spheroids that were observed before the inoculation (Fig. 1) were excluded in the remaining spheroid population. Slight deterioration in the spheroid surfaces began to be observed in 100% human plasma compared with those in synthesized culture medium. Perfusion time (hr) 
DISCUSSION
Focusing on the present requirement for the clinical use of BAL systems, we have developed a prototype of a high-performance bioreactor that allows hepatocytes to display their maximal metabolic capacity. This was accomplished by taking full advantage of a suspension culture bioreactor in combination with high-performance spheroid culture. Kasai et al. (9) reported that suspen sion culture of isolated dog hepatocytes prolonged the survival time of model liver failure dogs over two times.
Suspension of isolated porcine hepatocytes was also used in human clinical trials with significant life-saving effect (13) . However, such suspension culture type bio reactors have been considered unsuitable for BAL reac tors from some points of view, as discussed below.
Relatively larger reactor volume has been considered one of the disadvantages of suspension culture. This is due to its lower allowable cell density, which may lead to the requirement of large plasma volume. In our biore actor, however, the cell density was enhanced success- Figure 5 are also plotted as the mean of two runs with maximal errors (+).
fully up to 2.7 x 10 7 cells/ml by utilizing high-cell-den sity spheroids. This immobilized cell density in the bioreactor is comparable to those of usual packed-bedtype or hollow-fiber-type reactor for BALs (2, 3, 11, 16, 17, 19, 27, 28) . As long as suitable operation conditions were utilized, porcine hepatocyte spheroids were very stable even in high-cell-density suspension in terms of their functions, damage, and morphology.
Duration of culture has been another defect of sus pension culture type bioreactors. In the use of BALs by Watanabe et al. (27) as a bridge to orthotropic liver transplantation, however, one perfusion treatment lasted for at most 6 h. The used system was then replaced with a new one and additional repeated treatments were per formed if needed. This protocol is reasonable in main taining the efficacy of treatment, particularly for the treatment of patients with severe liver failure. Therefore, we think that display of maximal performance of a BAL is more important than its long-term functional duration as long as the current demand to BALs from the clinical side is concerned.
Unfortunately, in our study, we could not perform longer term perfusion experiment over around 12 h be cause of the clogging of the rotating filter with smalldiameter spheroids. Porcine hepatocyte spheroids in the reactor perfused with 100% human plasma still retained good cellular activities at around 8 h (Figs. 6, 7, and 8 ). We previously showed in rotational culture that porcine hepatocyte spheroids function up to a couple of days in 100% human plasma (25) . Recently, Gerlach et al. (4) reported much longer term perfusion treatment (40 h) of one human patient by one BAL. If such long-term per fusion protocol is shown to be safe and more effective than that of Watanabe et al. (27) , such new protocol would certainly be good in saving both the time and cost needed for BAL treatment. Therefore, even for our pres ent BAL, a much longer perfusion experiment is neces sary and worth trying after improving the present reactor design or operation conditions to retard the filter clog ging.
Some investigators recently began to use porcine he patocyte aggregates in BALs. Wu et al. (28) improved the functions of their collagen gel-containing hollow-fi ber (molecular weight cutoff was 100 kDa) bioreactor by utilizing porcine hepatocyte spheroids instead of dis persed cells. Irrespective of the molecular weights of metabolites, unit/cell number basis comparison showed that the functions of our bioreactor ( Table 2) were ap proximately two times higher than theirs: albumin secre tion of 1.0 ± 0.5 ug/10 6 cells/8 h; urea synthesis of 73 ± 3 nmol/10 6 cells/2 h; and oxygen consumption of 4.3 ± 0.5 nmol/10 6 cells/min (28) . The oxygen consumption rate of porcine hepatocytes measured by Wu et al. and us showed that the rate is less than half that of rat hepa tocytes, around 24 nmol/10 6 cells/min (20) . Presumably it is related to the smaller size of a porcine hepatocyte compared with that of a rat hepatocyte (22) . Kong et al. (11) also tried to improve their hollow-fiber-type biore actor by using collagen-coated microcarriers as an in ducer for hepatocyte aggregation. Our ammonium re moval was much higher and 7HC formation was slightly lower than those of their experiments using plasma of patients with fulminant hepatic failure. However, we could not compare directly between the data of their study and our study due to their lack of kinetic data. In addition, recent studies of Gerlach et al. (3) and Flendrig et al. (2) took advantage of aggregate culture of porcine hepatocytes in their BALs. The cells inoculated in the bioreactors packed with cell support materials formed spontaneously small aggregates and the total BAL per formance seemed to be enhanced because of the cell ag gregation. However, the data between their study and our study cannot be compared because of the differences in the functional indices employed.
The very rapid spheroid aggregation observed in one specific human plasma pool (run 2) was a serious and crucial phenomenon in applying porcine hepatocytebased BALs to human patients. In an experiment on dish level monolayer culture using the same plasma pool and hepatocyte preparation, the cells were destroyed within 2 h and only very low functions were detected (data not shown). Rozga et al. (21) reported almost the same phenomenon in their initial human clinical trial; that is, rapid necrosis of microcarrier-attached porcine hepato cytes coming into contact with the plasma of one partic-ular patient. A recent study from Uchino et al. (26) showed that about 7% of the human population has natu ral antibodies (preformed IgM) against porcine hepato cytes, and cultured hepatocytes in such specific plasma die very rapidly before functioning. Therefore, the phe nomenon observed in our experiment (run 2) does not mean the disadvantage of suspension culture of spher oids itself, but does manifest a crucial problem caused by some immunological reaction inherent to the use of porcine hepatocytes in BAL systems. Because we did not conduct any immunolgical analysis on this specific human plasma pool, future investigation is needed be fore concluding the exact mechanism. In any case, the observation suggests the importance of testing the com patibility between individual patient plasma and porcine hepatocytes used in a BAL in advance.
It should be noted that the 7EC metabolic capacities of the spheroid were lower than that of monolayer in terms of the four indices including 7EC intake and intra cellular 7HC formation (Table 1) . Various functional mea surements, such as ammonium detoxification, urea synthe sis, or albumin secretion, already showed that porcine hepatocyte spheroids have significantly higher functions on a unit/cell number basis (about two times) than con ventional monolayers (22, 25) . However, Kong et al. (11) also reported the lower 7HC production of porcine hepa tocyte aggregates than that of monolayers. Considering these studies, there is some possibility that the rates of some functional expressions where relatively hydropho bic substances are involved may be lowered by the dif fusion process in spheroids, but this issue needs future studies.
In conclusion, the developed prototype BAL based on high-cell-density suspension perfusion culture of por cine hepatocyte spheroids (4 x 10 9 cells in 150 ml) achieved significantly improved performance by mini mizing functional deterioration often associated with scaling up. Unit/cell number-based functional compari son, which has not been made well in previous studies, showed that almost the same cellular capacities were at tained in the BAL as those of small-scale culture. Such high performance was still maintained even when per fused with 100% human plasma. Rapid spheroid aggre gation and dysfunction in one human plasma pool mani fested a crucial issue inherent to porcine hepatocytebased BALs. Although this issue should be resolved carefully before starting clinical application, this proto type is one of promising BALs because it meets the present clinical demand by achieving maximal meta bolic activities even in a short term.
